Literature DB >> 15610733

The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.

Kelly Suino1, Li Peng, Ross Reynolds, Yong Li, Ji-Young Cha, Joyce J Repa, Steven A Kliewer, H Eric Xu.   

Abstract

Constitutive androstane receptor (CAR) induces xenobiotic, bilirubin, and thyroid hormone metabolism as a heterodimer with the retinoid X receptor (RXR). Unlike ligand-dependent nuclear receptors, CAR is constitutively active. Here, we report the heterodimeric structure of the CAR and RXR ligand binding domains (LBDs), which reveals an unusually large dimerization interface and a small CAR ligand binding pocket. Constitutive CAR activity appears to be mediated by the compact nature of the CAR LBD that displays several unique features including a shortened AF2 helix and helix H10, which are linked by a two-turn helix that normally adopts an extended loop in other receptors, and an extended helix H2 that stabilizes the canonical LBD fold by packing tightly against helix H3. These structural observations provide a molecular framework for understanding the atypical transcriptional activation properties of CAR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15610733     DOI: 10.1016/j.molcel.2004.11.036

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  81 in total

1.  Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation.

Authors:  Ryota Shizu; Makoto Osabe; Lalith Perera; Rick Moore; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

Review 2.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

Review 3.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 4.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

5.  CAR Suppresses Hepatic Gluconeogenesis by Facilitating the Ubiquitination and Degradation of PGC1α.

Authors:  Jie Gao; Jiong Yan; Meishu Xu; Songrong Ren; Wen Xie
Journal:  Mol Endocrinol       Date:  2015-09-25

6.  Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active.

Authors:  Laura J Lewis-Tuffin; Christine M Jewell; Rachelle J Bienstock; Jennifer B Collins; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

7.  Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry.

Authors:  Edward Wright; Jeremy Vincent; Elias J Fernandez
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

Review 8.  A current structural perspective on PXR and CAR in drug metabolism.

Authors:  Cameron D Buchman; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-05-30       Impact factor: 4.481

9.  Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.

Authors:  Na Wang; Qingan Zou; Jinxin Xu; Jiancun Zhang; Jinsong Liu
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

10.  Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor.

Authors:  X Edward Zhou; Kelly M Suino-Powell; Jun Li; Yuanzheng He; Jeffrey P Mackeigan; Karsten Melcher; Eu-Leong Yong; H Eric Xu
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.